Literature DB >> 26583938

Analysis of changes in maternal circulating angiogenic factors throughout pregnancy for the prediction of preeclampsia.

M C Honigberg1, D E Cantonwine2, A M Thomas2, K-H Lim3, S I Parry4, T F McElrath2.   

Abstract

OBJECTIVE: To assess whether changes in maternal angiogenic factors throughout pregnancy predict the development of preeclampsia. STUDY
DESIGN: Placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 receptor (sFlt-1) were measured in 2355 women at 10, 18, 26 and 35 weeks gestation. Receiver operator characteristic analysis was used to calculate test characteristics for changes in analytes between time points. Linear mixed-effects models generated slopes of analytes throughout pregnancy, which in turn were used as predictors in adjusted logistic regression models. RESULT: Changes in analytes yielded positive predictive values of 9 to 19% and negative predictive values of 93 to 97%. Individuals with lowest quartile slopes in PlGF had sixfold greater odds (95% confidence interval (CI): 3.5, 10.2) of preeclampsia compared with individuals in the highest quartile. With respect to sFlt-1, the highest quartile had 5.1 times greater odds (95% CI: 3.1, 8.4) than the lowest quartile.
CONCLUSION: Measuring the trend in PlGF and sFlt-1 across pregnancy segregates women at increased risk of preeclampsia. However, changes in these factors throughout pregnancy lack clinically useful predictive power.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26583938     DOI: 10.1038/jp.2015.170

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  32 in total

1.  Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease.

Authors:  Sarka Lisonkova; K S Joseph
Journal:  Am J Obstet Gynecol       Date:  2013-08-22       Impact factor: 8.661

2.  First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.

Authors:  Marc U Baumann; Nick A Bersinger; Markus G Mohaupt; Luigi Raio; Susan Gerber; Daniel V Surbek
Journal:  Am J Obstet Gynecol       Date:  2008-09       Impact factor: 8.661

3.  First-trimester prediction of preeclampsia in nulliparous women at low risk.

Authors:  Leslie Myatt; Rebecca G Clifton; James M Roberts; Catherine Y Spong; John C Hauth; Michael W Varner; John M Thorp; Brian M Mercer; Alan M Peaceman; Susan M Ramin; Marshall W Carpenter; Jay D Iams; Anthony Sciscione; Margaret Harper; Jorge E Tolosa; George Saade; Yoram Sorokin; Garland D Anderson
Journal:  Obstet Gynecol       Date:  2012-06       Impact factor: 7.661

4.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

5.  Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004.

Authors:  Anne B Wallis; Audrey F Saftlas; Jason Hsia; Hani K Atrash
Journal:  Am J Hypertens       Date:  2008-03-13       Impact factor: 2.689

Review 6.  Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia.

Authors:  R N Taylor; C J de Groot; Y K Cho; K H Lim
Journal:  Semin Reprod Endocrinol       Date:  1998

7.  Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.

Authors:  Sarosh Rana; S Ananth Karumanchi; Richard J Levine; Shivalingappa Venkatesha; Jose Alejandro Rauh-Hain; Hector Tamez; Ravi Thadhani
Journal:  Hypertension       Date:  2007-05-21       Impact factor: 10.190

8.  IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia?

Authors:  C W Redman; I L Sargent; A C Staff
Journal:  Placenta       Date:  2014-01-11       Impact factor: 3.481

9.  Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia.

Authors:  Sarosh Rana; Camille E Powe; Saira Salahuddin; Stefan Verlohren; Frank H Perschel; Richard J Levine; Kee-Hak Lim; Julia B Wenger; Ravi Thadhani; S Ananth Karumanchi
Journal:  Circulation       Date:  2012-01-18       Impact factor: 29.690

10.  Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort.

Authors:  Pia M Villa; Esa Hämäläinen; Annukka Mäki; Katri Räikkönen; Anu-Katriina Pesonen; Pekka Taipale; Eero Kajantie; Hannele Laivuori
Journal:  BMC Pregnancy Childbirth       Date:  2013-05-12       Impact factor: 3.007

View more
  8 in total

Review 1.  Immunology of hepatic diseases during pregnancy.

Authors:  Lars Bremer; Christoph Schramm; Gisa Tiegs
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

2.  Altered level of salivary placental growth factor is associated with preeclampsia.

Authors:  Shannon L Rao; Ada Taymoori; David T W Wong; Jill L Maron
Journal:  Placenta       Date:  2019-12-23       Impact factor: 3.481

3.  Early gestational profiling of oxidative stress and angiogenic growth mediators as predictive, preventive and personalised (3P) medical approach to identify suboptimal health pregnant mothers likely to develop preeclampsia.

Authors:  Enoch Odame Anto; David Antony Coall; Otchere Addai-Mensah; Yaw Amo Wiafe; William K B A Owiredu; Christian Obirikorang; Max Efui Annani-Akollor; Eric Adua; Augustine Tawiah; Emmanuel Acheampong; Evans Adu Asamoah; Xueqing Wang; Stephen Opoku; Derick Kyei Boakye; Haifeng Hou; Youxin Wang; Wei Wang
Journal:  EPMA J       Date:  2021-10-21       Impact factor: 6.543

4.  Urinary trace metals, maternal circulating angiogenic biomarkers, and preeclampsia: a single-contaminant and mixture-based approach.

Authors:  Paige A Bommarito; Stephani S Kim; John D Meeker; Rebecca C Fry; David E Cantonwine; Thomas F McElrath; Kelly K Ferguson
Journal:  Environ Health       Date:  2019-07-12       Impact factor: 5.984

5.  Genetic markers for preeclampsia in Peruvian women.

Authors:  José Pacheco-Romero; Oscar Acosta; Doris Huerta; Santiago Cabrera; Marlene Vargas; Pedro Mascaro; Moisés Huamán; José Sandoval; Rudy López; Julio Mateus; Enrique Gil; Enrique Guevara; Nitza Butrica; Diana Catari; David Bellido; Gina Custodio; Andrea Naranjo
Journal:  Colomb Med (Cali)       Date:  2021-02-26

6.  Maternal Levels of Perfluoroalkyl Substances (PFAS) during Early Pregnancy in Relation to Preeclampsia Subtypes and Biomarkers of Preeclampsia Risk.

Authors:  Paige A Bommarito; Kelly K Ferguson; John D Meeker; Thomas F McElrath; David E Cantonwine
Journal:  Environ Health Perspect       Date:  2021-10-12       Impact factor: 9.031

7.  Placental lesions and differential expression of pro-and anti-angiogenic growth mediators and oxidative DNA damage marker in placentae of Ghanaian suboptimal and optimal health status pregnant women who later developed preeclampsia.

Authors:  Enoch Odame Anto; David Antony Coall; Emmanuel Akomanin Asiamah; Osei-Owusu Afriyie; Otchere Addai-Mensah; Yaw Amo Wiafe; Wkba Owiredu; Christian Obirikorang; Max Efui Annani-Akollor; Nicholas Akinwale Titiloye; Eric Adua; Emmanuel Acheampong; Evans Asamoah Adu; Stephen Opoku; Agartha Odame Anto; Augustine Tawiah; Youxin Wang; Wei Wang
Journal:  PLoS One       Date:  2022-03-21       Impact factor: 3.240

Review 8.  Fontan Circulation Might be Associated with Peripartum Cardiomyopathy: A Review of Mechanistic and Clinical Aspects.

Authors:  Kenan Yalta; Ertan Yetkin; Gokay Taylan
Journal:  Curr Cardiol Rev       Date:  2021
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.